anticoagulant

(redirected from anticoagulant agent)
Also found in: Thesaurus, Medical, Encyclopedia.

an·ti·co·ag·u·lant

 (ăn′tē-kō-ăg′yə-lənt, ăn′tī-)
n.
A substance that slows or prevents the clotting of blood.
adj.
Acting as an anticoagulant.

an′ti·co·ag′u·la′tive (-lā′tĭv, -lə-tĭv) adj.

anticoagulant

(ˌæntɪkəʊˈæɡjʊlənt)
adj
(Medicine) acting to prevent or impair coagulation, esp of blood
n
(Pharmacology) an agent that prevents or impairs coagulation

an•ti•co•ag•u•lant

(ˌæn ti koʊˈæg yə lənt, ˌæn taɪ-)

adj.
1. Also, an•ti•co•ag•u•la•tive (-ˌleɪ tɪv, -lə tɪv) preventing coagulation, esp. of blood.
n.
2. an anticoagulant agent, as heparin.
[1900–05]

anticoagulant

A drug used to decrease the clotting ability of the blood, especially after heart surgery.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.anticoagulant - medicine that prevents or retards the clotting of bloodanticoagulant - medicine that prevents or retards the clotting of blood
dicoumarol, dicumarol - an anticoagulant drug that has now been largely replaced by warfarin
heparin, Lipo-Hepin, Liquaemin - a polysaccharide produced in basophils (especially in the lung and liver) and that inhibits the activity of thrombin in coagulation of the blood; it (trade names Lipo-Hepin and Liquaemin) is used as an anticoagulant in the treatment of thrombosis and in heart surgery
medicament, medication, medicinal drug, medicine - (medicine) something that treats or prevents or alleviates the symptoms of disease
Coumadin, warfarin - an anticoagulant (trade name Coumadin) use to prevent and treat a thrombus or embolus
Translations
antikoagulantti

anticoagulant

[ˈæntɪkəʊˈægjʊlənt]
A. ADJanticoagulante
B. Nanticoagulante m

anticoagulant

[ˌæntɪkəʊˈægjʊlnt] adj & nanticoagulante (m)

an·ti·co·ag·u·lant

n. anticoagulante, medicamento usado para evitar coágulos.

anticoagulant

adj & n anticoagulante m; lupus — anticoagulante lúpico
References in periodicals archive ?
They recommended a conservative follow-up approach in patients who had a history of coagulopathy and anticoagulant agent use, a negative ureterorenoscopic examination, and improvement in hematuria symptoms.
Warfarin (brand names Coumadin) is a first generation oral anticoagulant agent. It works by inhibiting the production of vitamin-dependent coagulation factors by the liver [1].
Electrospun fibers not only mimic extra cellular matrix but also play another role as carrier of anticoagulant agent like in this investigation and were found to support mechanical and burst strength for ABVs in our previous paper.
Background: Warfarin has been widely used for a long time as an oral anticoagulant agent. Warfarin is reported to have inflammatory role as well.
All blood samples were collected in tubes with EDTA (potassium ethylenediaminetetraacetate) which served as the anticoagulant agent. All the blood samples were analyzed by the hematology analyzer within two hours of sampling (MINDRAY BC-6800).The data was analyzed using the Statistical Package for Social Sciences (SPSS) software version 20.
For a long time, the vitamin K antagonist (VKA) warfarin had been used as an anticoagulant agent, but recently, novel oral anticoagulants (NOACs) have become an alternative prophylaxis for thromboembolism in patients with nonvalvular AF.
When the fatty material bursts, a clot can form unless an anticoagulant agent is being taken to reduce the risk of platelet aggregation.
6 January 2010 - US biopharmaceutical company ARYx Therapeutics Inc (NASDAQ: ARYX) said yesterday it has received guidance in writing from the US Food and Drug Administration (FDA) confirming that the existing development pathway remains acceptable to seek regulatory approval of its anticoagulant agent, tecarfarin (ATI-5923).
This approval, together with Eisai's other related products including Warfarin(R) (anticoagulant agent) and Vasolan(R) (calcium antagonistic antiarrthymic treatment which controls increased heart rate in paroxysmal atrial fibrillation/flutter), will enable Eisai to make further contributions to patients by offering treatment options for managing paroxysmal atrial fibrillation/flutter.
Capping of the catheter lumens with an anticoagulant agent is performed to avoid catheter clotting in the interdialytic period.

Full browser ?